WELL Launches its Second-Generation AI powered Physician Co-pilot with Chronic Disease Detection Powered by HEALWELL AI

• WELL and HEALWELL AI have launched the second-generation of WELL AI Decision Support (“WAIDS”), which now features advanced chronic disease screening for diseases like chronic kidney disease, hypertension, and diabetes, enabling patient risk stratification.
• The updated WAIDS tool identifies over one hundred diseases and delivers actionable clinical insights at the point of care, contributing to the management of chronic disease-related costs in Canada, which are estimated to be approximately $190 billion annually and affected 45.1% of all Canadians in 2021.

VANCOUVER, British Columbia and TORONTO, May 02, 2024 (GLOBE NEWSWIRE) -- WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (“WELL”), a digital health company focused on tech-enabling healthcare providers, and its investee company, HEALWELL AI (TSX: AIDX) (“HEALWELL”), are pleased to announce the launch of the second generation WELL AI Decision Support, (or "WAIDS"). This enhanced version which features advanced chronic disease screening arrives just six months after the initial launch, which was primarily focused on rare disease detection.

The upgraded WAIDS now includes screening capabilities for numerous chronic diseases such as chronic kidney disease, hypertension, and diabetes, enabling risk stratification of patients into high, medium, or low risk categories. This expansion broadens WAIDS's utility in detecting more than one hundred rare and chronic diseases, providing clinically validated insights that identify care gaps and equip clinicians with actionable information at the point of care.

Dr. Michael Frankel, Chief Medical Officer of WELL, commented on the new capabilities, "Adding chronic disease detection is a game-changer for our AI powered physician co-pilot tools. I have personally used this tool in my practice and found it to be of tremendous help and support. The tool compliantly scans my data and provides me with an overview of a number of key diseases as well as insights on which patients could be at higher risk or exposure to such diseases."

The technology behind WAIDS is powered by HEALWELL AI who has been helping physicians save lives for the past four years with its best-in-class rare disease detection capabilities. This launch represents another significant step forward in WELL and HEALWELL's ongoing collaboration to transform healthcare through data science and innovative technology.